Copyright
©The Author(s) 2015.
World J Diabetes. Jun 10, 2015; 6(5): 759-773
Published online Jun 10, 2015. doi: 10.4239/wjd.v6.i5.759
Published online Jun 10, 2015. doi: 10.4239/wjd.v6.i5.759
Ref. | Country | Period | Design | Setting | Sample size | Mean or median age (yr) | Male (%) | Type and duration of diabetes (yr) | Duration FUP | Method for CKD assessment | |||
Proteinuria | MDRD | Urine ACR | Cockroft-Gault | ||||||||||
Motala et al[37], 2001 | South Africa | Not precised | Retrospective cohort study | Clinic, urban | 219 | 39.5 T1DM; 58.4 T2DM | 19.6 | 16.10 T1DM; 18.6 T2DM | At least 10 yr | persistent proteinuria (Dipstick) | |||
Elbagir et al[26], 1995 | Sudan | Jan-July 1992 | Cross-sectional, self-selected sampling | Clinic, urban | 128 | 31.5 (15-75) | 48.4 | Insulin-treated; 9 (1-40) | NA | Proteinuria (Dipstick) | |||
Sobngwi et al[44], 1999 | Cameroon | Not precised | Cross-sectional, self-selected sampling | Clinic, urban | 64 | 37.4 normotensive T1DM; 51.7 normotensive T2DM; 57.9 hypertensive T1DM | 57.8 | 6.7 normotensive T1DM; 4.7 normotensive T2DM; 4.8 hypertensive T1DM | NA | Proteinuria | |||
Katchunga et al[30], 2010 | DR congo | 2005-2007 | Cross-sectional, self-selected sampling | Clinic, urban | 98 | 58 (10.4) | 35.7 | 7.3 T2DM | NA | MDRD (corrected for Blacks) | |||
Choukem et al[22], 2012 | Cameroon | Jan 2008- Oct 2010 | Cross-sectional, self-selected sampling | Clinic, urban | 420 | 56.7 | 49 | 4 (1-9) T2DM | NA | Proteinuria (Dipstick) | |||
Keeton et al[31], 2004 | South Africa | Not precised | Prospective cohort, self-selected sampling | Clinic, urban | 59 | 62 | 35.6 | 17.8 T2DM | 12 yr | Urine ACR | |||
Pruijm et al[39], 2008 | Seychelles | 2004 | Cross-sectional; random sex and age-stratified sample | Population | 1218 (whole sample, including diabetic patients) | Not precised | 45.9 | Newly diagnosed patients | NA | Urine ACR | |||
Alebiosu[16], 2003 | Nigeria | Jan 2000 June 2001 | Cross-sectional, self-selected sampling | Clinic, urban | 342 | 6.5 T1DM; 9.4 T2DM | 53.8 | 26 T1DM; 53.4 T2DM | NA | Persistent proteinuria | |||
Bouaziz et al[20], 2012 | Tunisia | Jan 2008Dec 2010 | Cross-sectional, self-selected sampling | Clinic, urban | 73 | 59.3 | 23.3 | T2DM 10.6 | NA | Proteinuria | |||
Ajayi et al[15], 2014 | Nigeria | Not precised | Retrospective cross-sectional | Clinic, urban | 65 | Not available | Not available | T2DM | NA | MDRD | |||
Levitt et al[32], 1997 | South Africa | July-December 1992 | Cross-sectional, stratified random sampling | Clinic, urban | 243 | 56.4 | 38.3 | 8 T2DM and T1DM | NA | Persistent proteinuria | Urine ACR | ||
Majaliwa et al[34], 2007 | Tanzania | June 2005- Feb 2006 | Cross-sectional, self-selected sampling | Clinic, urban | 99 | 12.6 | 42.4 | 4.76 T1DM | NA | Proteinuria | |||
Marshall et al[36], 2013 | Rwanda | June 2009-Nov 2010 | Cross-sectional, self-selected sampling | Clinic, urban | 286 | 18.6 | 46.5 | 3.4 T1DM | NA | Proteinuria | Urine ACR | ||
Alebiosu et al[18], 2003 | Nigeria | Sept 1999- August 2002 | Cross-sectional, self-selected sampling | Clinic, urban | 465 | Not precised | Not precised | T2DM | NA | Proteinuria | |||
Gill et al[28], 2005 | South Africa | From 1982 to 2002 | Prospective cohort, self-selected sampling | Clinic, urban | 88 | 22 at onset | 52 | T1DM | 20 yr | ||||
Djrolo et al[24], 2001 | Benin | Not indicated | Cross-sectional | Clinic, urban | 152 | 53.3 | 65.8 | T1DM and T2DM | NA | Proteinuria | |||
Rotchford et al[43], 2002 | South Africa | 1999 | Cross-sectional, self-selected sampling | Clinic, rural | 253 | 56.5 | 26.9 | 42.2; T1DM and T2DM | NA | Urine ACR | |||
Rissassi et al[42], 2009 | DR congo | 11 june 2008 to 30 july 2008 | Cross-sectional, self-selected sampling | Clinic, urban | 181 | 19.1 | 38.7 | 57.6 T1DM | NA | Urine ACR | |||
Rahlenbeck et al[40], 1997 | Ethiopia | January - April 1995 | Cross-sectional, self-selected sampling | Clinic, urban | 170 | 31.4 T1DM; 56.7 T2DM | 60 | 5.9 T1DM; 6.0 T2DM | NA | Proteinuria | |||
Wanjohi et al[45], 2002 | Kenya | June 2000 - January 2001 | cross-sectional, self-selected sampling | Clinic, urban | 100 | 53.7 | 37 | 10.3 T2DM | NA | Albuminuria | |||
Nambuya et al[38], 1996 | Uganda | 1 January 1993 - 10 August 1994 | Cross-sectional, self-selected sampling | Clinic, urban/urban (origin of participants) | 252 | Not precised | 46.4 | 45 (range 30-69)T2DM and T1DM | NA | Proteinuria | |||
Rasmussen et al[41], 2013 | Zambia | February - April 2011 | Cross-sectional, self-selected sampling | Clinic, rural | 101 | 50 (range 50-68) | 37.3 | T2DM and T1DM | NA | Urine ACR | |||
Bentata et al[19], 2013 | Morocco | From September 2006 | Prospective cohort study | Clinic, urban | 72 | 29.5 | 69.4 | 17 (11-20) T1DM | 5 yr | Proteinuria | MDRD | ||
Gill et al[27], 2008 | Ethiopia | Not precised | Cross-sectional, self-selected sampling | Clinic, rural | 105 | 41 | 70.5 | 7 T1DM and T2DM | NA | Urine ACR | |||
Bouzid et al[21], 2011 | Tunisia | June 2006 - July 2008 | Cross-sectional, self-selected sampling | Clinic, urban | 689 | 60 | 39.3 | 11 T2DM | NA | Proteinuria | Cockroft-Gault | ||
Janmohamed et al[29], 2013 | Tanzania | October 2011 - March 2012 | Cross-sectional, self-selected sampling | Clinic, urban | 369 | 54 (IQR 45-62) | 46.6 | 6 (3-11)T1DM (6.2%) and T2DM (93.8%) | NA | Cockroft-Gault | |||
Danquah et al[23], 2012 | Ghana | August 2007 - June 2008 | Cross-sectional, self-selected sampling | Clinic, urban | 675 | 54.7 | 25 | T2DM | NA | Proteinuria | |||
Lutale et al[33], 2007 | Tanzania | July 2003 - March 2004 | Cross-sectional, self-selected sampling | Clinic, urban | 244 | T1DM 21(range 4-44.8)T2DM 53 (range 23.5-85) | 46.3 | T1DM 3 (0-17)T2DM 4 (range 0-25) | NA | Proteinuria | Cockroft-Gault | ||
Worku et al[46], 2010 | Ethiopia | October 2008 | Cross-sectional, self-selected sampling | Clinic, urban | 305 | 44.4 | 62.9 | T1DM and T2DM; 53.4% less than 5 yr and 33.8% 5-9 yr | NA | Proteinuria | |||
Makulo et al[35], 2010 | DR Congo | 30 March - 24 April 2007 | Cross-sectional, self-selected sampling | Population-based, Urban | 81 | Not precised | Not precised | No precision | NA | MDRD | Urine ACR | ||
Eghan et al[25], 2007 | Ghana | January - July 2005 | Cross-sectional, self-selected sampling | Clinic, urban | 109 | 54.1 | 28 | T1DM and T2DM 10.7 | NA | Proteinuria | |||
Alebiosu et al[17], 2004 | Nigeria | January 2000 - June 2001 | Case (T2DM with persistent proteinuria-control (T2DM patients nephropathy) | Clinic, urban | 162 | 53.4 | 50 | T2DM9.4 cases, 5.5 controls | NA |
- Citation: Noubiap JJN, Naidoo J, Kengne AP. Diabetic nephropathy in Africa: A systematic review. World J Diabetes 2015; 6(5): 759-773
- URL: https://www.wjgnet.com/1948-9358/full/v6/i5/759.htm
- DOI: https://dx.doi.org/10.4239/wjd.v6.i5.759